This Next-Gen Obesity Drug: Can It Save Novo Nordisk?
Novo Nordisk faces intense pressure in the fast-growing obesity treatment space. This article dives into whether this...
Why Do Active Funds Underperform Benchmark? This overview breaks down fees, manager skill, and market efficiency to explain gaps in performance and how to navigate them.
22,441 articlesNovo Nordisk faces intense pressure in the fast-growing obesity treatment space. This article dives into whether this...
The weight loss field is heating up, with Novo Nordisk leading the GLP-1 wave and Amgen pursuing a smaller, more sele...
In 2026, the global air fleet is being renewed around a handful of high-performance fighters. Investors are watching ...
Bitcoin’s leverage ratio drops on major venues amid rising risk-off mood, as analysts watch whether spot buying retur...
PennyMac’s Third-Party Origination unit rolls out a seven-program non-QM suite to broaden options for borrowers with ...
Bitcoin moved higher amid mixed signals: a large withdrawal of BTC from exchanges coinciding with rising futures shor...
Intuit has faced a sharp share-price pullback this year. This guide breaks down the why, the risk factors, and what i...
Mastercard unveiled a sweeping Crypto Partner Program that brings together Ripple, Binance, PayPal and dozens more to...
The Federal Trade Commission has secured a $47 million restitution package to renters misled by undisclosed fees at I...
Reality show prizes often come with strings. This article breaks down what happens when the prize promises don’t alig...
UiPath shares fell about 6% after a strong earnings print, prompting analysts to debate whether the AI automation the...
A fresh look at how to read Lifetime Brands' Q4 2025 earnings transcript. This guide explains key metrics, growth dri...